• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Particle Health Raises $25M to Scale Health Data Exchange API Platform

by Fred Pennic 07/12/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Particle Health, a New York-based API platform for advanced healthcare data exchange, , today announced its Series B financing of $25 million led by Canvas Ventures with participation from Menlo Ventures, Story Ventures, and Pruven Capital. The financing brings the organization’s total capital raised to $39.3M.

– From a healthcare infrastructure perspective, the company is leading the industry in applying the next-generation FHIR data format to make interoperability easier.

Scale Patient Data Access and Insight Offering to Make Better Care Outcomes Possible

Founded in 2018, Particle Health has built the integrations and APIs that enable a modern, seamless data experience for healthcare companies. Particle Health’s comprehensive API uniquely combines data from 270 million-plus patients’ medical records by aggregating and unifying healthcare records from thousands of sources. The platform then standardizes the data to FHIR R4 to ensure that they are usable at scale. With this approach, providers are able to easily obtain clinical data points without complex technology integrations, putting actionable patient health data at their fingertips. On average, the Particle solution delivers an exceptional 90 percent success rate in obtaining a patient’s records at a rate of 105 records per patient, per search.

Applying Next-Gen FHIR Data Format to Drive Interoperability

Particle is leading the industry in applying the next-generation FHIR data format to make interoperability easier. With this approach, the company has created the most adaptable, easy-to-use solution for healthcare organizations, digital health companies, and startups to securely exchange patient data. In the past year alone, Particle has seen a 450 percent increase in annual recurring revenue and a 300 percent increase in customers. The team has expanded from 11 to 40 people since its $12 million Series A led by Menlo Ventures in 2020, and accelerated growth is anticipated.

“Particle Health was founded with the mission to dramatically change lives through access to vital medical data. Since day one, we’ve established ourselves as an industry leader that standardizes records, identifies key pieces of information, and focuses on patient attributes that lead to more clinically relevant decision making,” said Troy Bannister, Particle Health co-founder and CEO. “With this latest round of funding, our team is looking forward to evolving the capabilities of our API platform further to empower our users with even more meaningful and actionable data.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: API, APIs in Healthcare, digital health, FHIR, Health IT Interoperability, Healthcare Data, interoperability, medical records, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |